Sarcopenia Adversely Impacts Postoperative Complications Following Resection or Transplantation in Patients with Primary Liver Tumors

[1]  Celia P. Corona-Villalobos,et al.  Response stratification and survival analysis of hepatocellular carcinoma patients treated with intra‐arterial therapy using MR imaging‐based arterial enhancement fraction , 2014, Journal of magnetic resonance imaging : JMRI.

[2]  J. Trachtenberg,et al.  Effect of total-body prehabilitation on postoperative outcomes: a systematic review and meta-analysis. , 2014, Physiotherapy.

[3]  Celia P. Corona-Villalobos,et al.  Interobserver agreement of semi-automated and manual measurements of functional MRI metrics of treatment response in hepatocellular carcinoma. , 2014, European journal of radiology.

[4]  T. Yamanaka,et al.  Sarcopenia as a predictor of prognosis in patients following hepatectomy for hepatocellular carcinoma , 2013, The British journal of surgery.

[5]  Rebecca M. Dodson,et al.  Impact of Sarcopenia on Outcomes Following Intra-arterial Therapy of Hepatic Malignancies , 2013, Journal of Gastrointestinal Surgery.

[6]  Johnny C. Hong,et al.  The Evolution of Liver Transplantation During 3 Decades: Analysis of 5347 Consecutive Liver Transplants at a Single Center , 2013, Annals of surgery.

[7]  Celia P. Corona-Villalobos,et al.  Unresectable hepatocellular carcinoma: MR imaging after intraarterial therapy. Part II. Response stratification using volumetric functional criteria after intraarterial therapy. , 2013, Radiology.

[8]  Celia P. Corona-Villalobos,et al.  Unresectable hepatocellular carcinoma: MR imaging after intraarterial therapy. Part I. Identification and validation of volumetric functional response criteria. , 2013, Radiology.

[9]  J. Silver,et al.  Cancer prehabilitation: an opportunity to decrease treatment-related morbidity, increase cancer treatment options, and improve physical and psychological health outcomes. , 2013, American journal of physical medicine & rehabilitation.

[10]  T. Pawlik,et al.  Impact of complications on long‐term survival after resection of colorectal liver metastases , 2013, The British journal of surgery.

[11]  John Eng,et al.  Neuroendocrine liver metastasis treated by using intraarterial therapy: volumetric functional imaging biomarkers of early tumor response and survival. , 2013, Radiology.

[12]  Kevin W Eliceiri,et al.  NIH Image to ImageJ: 25 years of image analysis , 2012, Nature Methods.

[13]  Michael A. Choti,et al.  Impact of Sarcopenia on Outcomes Following Resection of Pancreatic Adenocarcinoma , 2012, Journal of Gastrointestinal Surgery.

[14]  Michael J. Englesbe,et al.  Sarcopenia as a Prognostic Factor among Patients with Stage III Melanoma , 2011, Annals of Surgical Oncology.

[15]  Mark G van Vledder,et al.  Sarcopenia negatively impacts short-term outcomes in patients undergoing hepatic resection for colorectal liver metastasis. , 2011, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[16]  Johnny C. Hong,et al.  Comparative analysis of resection and liver transplantation for intrahepatic and hilar cholangiocarcinoma: a 24-year experience in a single center. , 2011, Archives of surgery.

[17]  A. Tsung,et al.  Major liver resection in elderly patients: a multi-institutional analysis. , 2011, Journal of the American College of Surgeons.

[18]  A. Kibel.  Combined Resistance and Aerobic Exercise Program Reverses Muscle Loss in Men Undergoing Androgen Suppression Therapy for Prostate Cancer Without Bone Metastases: A Randomized Controlled Trial , 2010 .

[19]  Douglas E Schaubel,et al.  Sarcopenia and mortality after liver transplantation. , 2010, Journal of the American College of Surgeons.

[20]  L. Birdsell,et al.  Low body mass index and sarcopenia associated with dose-limiting toxicity of sorafenib in patients with renal cell carcinoma. , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

[21]  M. Makary,et al.  Frailty as a predictor of surgical outcomes in older patients. , 2010, Journal of the American College of Surgeons.

[22]  L. Birdsell,et al.  Association of skeletal muscle wasting with treatment with sorafenib in patients with advanced renal cell carcinoma: results from a placebo-controlled study. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  Lisa Martin,et al.  Sarcopenia in an Overweight or Obese Patient Is an Adverse Prognostic Factor in Pancreatic Cancer , 2009, Clinical Cancer Research.

[24]  V. Velanovich,et al.  Preoperative Frailty and Quality of Life as Predictors of Postoperative Complications , 2009, Annals of surgery.

[25]  M. Choti,et al.  Rates and Patterns of Recurrence Following Curative Intent Surgery for Colorectal Liver Metastasis: An International Multi-Institutional Analysis of 1669 Patients , 2009, Annals of surgery.

[26]  M. Choti,et al.  Predictors of Survival After Resection of Early Hepatocellular Carcinoma , 2009, Annals of surgery.

[27]  Jean-Pierre Michel,et al.  Frailty Syndrome: A Transitional State in a Dynamic Process , 2009, Gerontology.

[28]  M. Choti,et al.  The volume-outcomes effect in hepato-pancreato-biliary surgery: hospital versus surgeon contributions and specificity of the relationship. , 2009, Journal of the American College of Surgeons.

[29]  C. Sima,et al.  Re-weighting the model for end-stage liver disease score components. , 2008, Gastroenterology.

[30]  J. Sloan,et al.  Patient‐physician disagreement regarding performance status is associated with worse survivorship in patients with advanced cancer , 2008, Cancer.

[31]  Tony Reiman,et al.  Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. , 2008, The Lancet. Oncology.

[32]  G. Gores,et al.  Liver Transplantation with Neoadjuvant Chemoradiation is More Effective than Resection for Hilar Cholangiocarcinoma , 2005, Annals of surgery.

[33]  Simina C. Fluture,et al.  Small pulmonary nodules: reproducibility of three-dimensional volumetric measurement and estimation of time to follow-up CT. , 2004, Radiology.

[34]  M. Revel,et al.  Are two-dimensional CT measurements of small noncalcified pulmonary nodules reliable? , 2004, Radiology.

[35]  John A. Cowan,et al.  Hepatic resection in the United States: indications, outcomes, and hospital procedural volumes from a nationally representative database. , 2003, Archives of surgery.

[36]  Yuman Fong,et al.  Improvement in Perioperative Outcome After Hepatic Resection: Analysis of 1,803 Consecutive Cases Over the Past Decade , 2002, Annals of surgery.

[37]  R. Busuttil,et al.  Liver transplantation for cholangiocellular carcinoma: Analysis of a single‐center experience and review of the literature , 2001, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[38]  R. Sanford,et al.  Morbidity of Second-Look Surgery in Pediatric Central Nervous System Tumors , 2001, Pediatric Neurosurgery.

[39]  J. Sloan,et al.  A simple stratification factor prognostic for survival in advanced cancer: the good/bad/uncertain index. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[40]  C. Meyer,et al.  Liver transplantation for cholangiocarcinoma: results in 207 patients. , 2000, Transplantation.

[41]  P. Rudolph,et al.  Prognostic indicators for response to therapy and survival in patients with metastatic renal cell cancer treated with interferon alpha-2 beta and vinblastine. , 1996, Urology.

[42]  M. Tamburini,et al.  Karnofsky and ECOG performance status scoring in lung cancer: a prospective, longitudinal study of 536 patients from a single institution. , 1996, European journal of cancer.

[43]  P. Clavien,et al.  Definition and Classification of Negative Outcomes in Solid Organ Transplantation Application in Liver Transplantation , 1994, Annals of surgery.

[44]  M. List,et al.  A performance status scale for head and neck cancer patients , 1990, Cancer.

[45]  V. Mor,et al.  Clinical symptoms and length of survival in patients with terminal cancer. , 1988, Archives of internal medicine.

[46]  L. Laliberte,et al.  The Karnofsky performance status scale: An examination of its reliability and validity in a research setting , 1984, Cancer.

[47]  Geerard L Beets,et al.  Functional compromise reflected by sarcopenia, frailty, and nutritional depletion predicts adverse postoperative outcome after colorectal cancer surgery. , 2015, Annals of surgery.

[48]  M. Beaussier,et al.  [Prehabilitation. Preparing patients for surgery to improve functional recovery and reduce postoperative morbidity]. , 2014, Annales francaises d'anesthesie et de reanimation.

[49]  M. Beaussier,et al.  La préhabilitation. Préparer les patients à la chirurgie pour améliorer la récupération fonctionnelle et réduire la morbidité postopératoire , 2014 .

[50]  W. Heindel,et al.  Volumetric measurements of pulmonary nodules at multi-row detector CT: in vivo reproducibility , 2003, European Radiology.